| Title |
Impact of Prior Treatment on the Efficacy of Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic MelanomaImpact of Prior Treatment on TIL for Metastatic Melanoma
|
|---|---|
| Published in |
Clinical Cancer Research, August 2021
|
| DOI | 10.1158/1078-0432.ccr-21-1171 |
| Pubmed ID | |
| Authors |
Samantha J. Seitter, Richard M. Sherry, James C. Yang, Paul F. Robbins, Mackenzie L. Shindorf, Amy R. Copeland, Christine T. McGowan, Monica Epstein, Thomas E. Shelton, Michelle M. Langhan, Zulmarie Franco, David N. Danforth, Donald E. White, Steven A. Rosenberg, Stephanie L. Goff |
X Demographics
The data shown below were collected from the profiles of 9 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 3 | 33% |
| Germany | 1 | 11% |
| United Kingdom | 1 | 11% |
| Unknown | 4 | 44% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 8 | 89% |
| Science communicators (journalists, bloggers, editors) | 1 | 11% |
Mendeley readers
The data shown below were compiled from readership statistics for 50 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 50 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 10 | 20% |
| Researcher | 10 | 20% |
| Other | 4 | 8% |
| Unspecified | 3 | 6% |
| Student > Bachelor | 3 | 6% |
| Other | 4 | 8% |
| Unknown | 16 | 32% |
| Readers by discipline | Count | As % |
|---|---|---|
| Immunology and Microbiology | 10 | 20% |
| Medicine and Dentistry | 8 | 16% |
| Agricultural and Biological Sciences | 8 | 16% |
| Unspecified | 3 | 6% |
| Biochemistry, Genetics and Molecular Biology | 2 | 4% |
| Other | 3 | 6% |
| Unknown | 16 | 32% |
Attention Score in Context
This research output has an Altmetric Attention Score of 101. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 October 2023.
All research outputs
#397,245
of 24,565,648 outputs
Outputs from Clinical Cancer Research
#203
of 13,050 outputs
Outputs of similar age
#10,195
of 423,055 outputs
Outputs of similar age from Clinical Cancer Research
#7
of 139 outputs
Altmetric has tracked 24,565,648 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,050 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.5. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 423,055 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 139 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.